CIK 0001422143
- Non-accelerated filer
- Smaller reporting company
Kura Oncology, Inc.
Sign in to watch- Ticker
- KURA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 611547851
- Phone
- +1 858-500-8800
- Business address
- 4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO, CA, 92121
- Former names
- ZETA ACQUISITION CORP III
- Open-market buys, last 90 days
- $4,248,530
- in 3 filings
- Open-market sales, last 90 days
- $1,978,236
- in 12 filings, $396K under 10b5-1 plans
Net +$2,270,294. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- WILSON TROY EDWARD +$4.2M President and CEO 3 filings
- Leoni Mollie −$747K Chief Medical Officer sold 45% of stake
- Powl Brian T. −$579K Chief Commercial Officer sold 35% of stake
- Burrows Francis −$225K Chief Scientific Officer sold 33% of stake
- FORD KATHLEEN −$192K Chief Operating Officer sold 14% of stake
Reading 38 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-30 | DALE STEPHEN Chief Medical Officer | Sale | −4,825 | $21.55 | $104K | 38,817 |
| 2024-01-29 | DALE STEPHEN Chief Medical Officer | Sale | −4,400 | $17.80 | $78K | 46,400 |
| 2024-01-29 | DALE STEPHEN Chief Medical Officer | Sale | −2,758 | $17.80 | $49K | 43,642 |
| 2024-01-02 | DALE STEPHEN Chief Medical Officer | Grant or award · Option to purchase common stock | +185,000 | 185,000 | ||
| 2023-02-16 | DALE STEPHEN Chief Medical Officer | Grant or award | +23,125 | 50,800 | ||
| 2023-02-16 | DALE STEPHEN Chief Medical Officer | Grant or award · Option to purchase common stock | +185,000 | 185,000 | ||
| 2023-01-27 | DALE STEPHEN Chief Medical Officer | Sale | −4,385 | $13.89 | $61K | 32,515 |
| 2023-01-27 | DALE STEPHEN Chief Medical Officer | Sale | −4,840 | $13.87 | $67K | 27,675 |
| 2022-01-26 | DALE STEPHEN Chief Medical Officer | Grant or award | +36,900 | 36,900 | ||
| 2022-01-26 | DALE STEPHEN Chief Medical Officer | Grant or award · Option to purchase common stock | +261,000 | 261,000 | ||
| 2021-01-26 | DALE STEPHEN Chief Medical Officer | Grant or award · Option to purchase common stock | +100,000 | 100,000 | ||
| 2020-08-24 | DALE STEPHEN Chief Medical Officer | Grant or award · Option to purchase common stock | +200,000 | 200,000 |
Page 1 of 1 · 12 trades